Indapamide

Hazard statements (CLP)

H361d, H362

Code

Statements

H361d

Suspected of damaging the unborn child

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child. Effects on or via lactation H362: May cause harm to breast-fed children.

Signal word

Warning Warning

Hazard statements

H361d Suspected of damaging the unborn child. H362 May cause harm to breast-fed children. H362 May cause harm to breast-fed children. H361d Suspected of damaging the unborn child.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dusts or mists. P263 Avoid contact during pregnancy and while nursing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none Reduced Labeling (<= 125 ml) none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.